TY - JOUR ID - 3358 TI - New Health Technologies: A UK Perspective; Comment on “Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies” JO - International Journal of Health Policy and Management JA - IJHPM LA - en SN - AU - Parvizi, Nassim AU - Parvizi, Sahar AD - Oxford University Hospitals NHS Foundation Trust, Oxford, UK AD - Moorfields Eye Hospital NHS Foundation Trust, London, UK Y1 - 2017 PY - 2017 VL - 6 IS - 12 SP - 721 EP - 722 KW - Health Technology KW - Health Technology Assessment (HTA) KW - National Institute of Health Research (NIHR) KW - National Institute for Health and Care Excellence (NICE) DO - 10.15171/ijhpm.2017.59 N2 - New health technologies require development and evaluation ahead of being incorporated into the patient care pathway. In light of the recent publication by Lehoux et al who discuss the role of entrepreneurs, investors and regulators in providing value to new health technologies, we summarise the processes involved in making new health technologies available for use in the United Kingdom. UR - https://www.ijhpm.com/article_3358.html L1 - https://www.ijhpm.com/article_3358_eaa713a92c3148cf2ace72933620b97c.pdf ER -